Assyro AI

FDA Orange Book · active-ingredient family

Rimantadine hydrochloride

Rimantadine hydrochloride is approved as 2 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:FLUMADINE · NDA 019649

2

Brand (NDA)

3

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · syrup, tablet

ProductApplicantApplicationTEApproved
FLUMADINERLDSUN PHARM INDS INCNDA 019649Sep 17, 1993
FLUMADINEFOREST LABSNDA 019650Sep 17, 1993

Generic (ANDA) products (3)

ProductApplicantApplicationTEApproved
RIMANTADINE HYDROCHLORIDECHARTWELL RXANDA 076375Jan 14, 2003
RIMANTADINE HYDROCHLORIDEIMPAX LABSANDA 076132Aug 30, 2002
RIMANTADINE HYDROCHLORIDEIMPAX LABS INCANDA 075916Nov 02, 2001

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Rimantadine hydrochloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.